Anzeige
Mehr »
Freitag, 24.07.2026 - Börsentäglich über 12.000 News
Aktie im Fokus: Die nächste Meldung könnte der Trigger sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
228 Leser
Artikel bewerten:
(1)

Simmons Hanly Conroy Named Partner Jayne Conroy Honored with 2026 "David Egilman Make the World a Better Place Award"

The award recognizes Conroy's three decades of landmark litigation against corporate wrongdoing, from the first cases against Purdue Pharma to leadership of the national opioid and social media addiction litigation.

NEW YORK CITY, NY / ACCESS Newswire / July 23, 2026 / Simmons Hanly Conroy is proud to announce that Named Partner Jayne Conroy is the recipient of the 2026 "David Egilman Make the World a Better Place Award," presented in recognition of her service to the legal community and the world.

Conroy was chosen by the award's selection committee, which is headed by Attorney Mark Lanier. The award honors the legacy of Dr. David Egilman of Brown University, a double board-certified physician who saved countless lives over his career through his unwavering quest to seek and proclaim the truth.

"As a doctor, I can treat one cancer patient at a time," Dr. Egilman once said of his work, explaining why he devoted his career to expert testimony in over 600 trials. "But by being here, I have the potential to save millions."

Created upon Dr. Egilman's passing in 2024, the award is now in its third year, and Conroy is its third recipient.

For more than 30 years, Conroy has done from the counsel table what Dr. Egilman did from the witness chair: building the cases that tell the truth to juries and holding powerful corporations accountable for concealing harm.

In 2003, with the support of firm partners Paul Hanly and John Simmons, Conroy was the first to take on Purdue Pharma over OxyContin - decades before the opioid crisis dominated national headlines. Her work uncovering the documents and the pharmaceutical industry's role in the epidemic laid the foundation for the national opioid litigation, which has now amassed more than $60 billion for communities across the country.

Following Hanly's death, Conroy stepped forward as co-lead counsel in the national opioid litigation, representing tens of thousands of American communities and helping secure the first nationwide opioid verdict in U.S. history.

Her selection also reflects her powerful and impactful leadership roles in dozens of other cases, including the Pinnacle hip implant litigation, the Volkswagen emissions MDL, and litigation on behalf of families impacted by the September 11th terrorist attacks.

Today, Conroy is active in the social media adolescent addiction litigation, where she recently helped bring the first social media addiction case against Meta and Google to a successful conclusion.

"David Egilman treated one patient at a time and decided that wasn't enough. Jayne Conroy could have built a comfortable career and decided that wasn't enough either," Lanier said. "Both of them looked at the suffering of people they would never meet and said: That one's mine to fight for too. That is what it means to make the world a better place. Not a verdict. A vow."

Conroy worked directly with Dr. Egilman for decades over the course of her career. In accepting the award, she reflected on his legacy: "David Egilman pushed and challenged those around him. David always spoke and found the truth. He would find every lie, every failure, and every misrepresentation. I hope I continue what he did, which was to uncover and illuminate every bad deed."

About Simmons Hanly Conroy LLP

Simmons Hanly Conroy, with over 300 employees, including over 100 attorneys practicing nationwide, is one of the country's largest plaintiff law firms dedicated to holding corporations responsible for wrongdoing. Primary areas of litigation include mesothelioma and asbestos, pharmaceutical and medical device injuries, consumer protection class actions, environmental injuries and protection, and complex personal injury. The firm's attorneys have been appointed to leadership in numerous national multidistrict litigations, including prescription opioids, Vioxx, Yaz, Toyota unintended acceleration, BP Deepwater Horizon Oil Spill, DePuy Pinnacle, Uber Rideshare sexual assault, Marine Corps Base Camp Lejeune, Norfolk Southern East Palestine train derailment, social media adolescent addiction, hair relaxer products injury, and the Volkswagen emission scandal. For over 25 years, the firm has successfully secured $11 billion in verdicts and settlements for thousands of clients nationwide and is a major supporter of asbestos-related cancer research. Offices are located in Alton, Illinois; Boston; Los Angeles; Miami; New York City; San Francisco; and St. Louis. Read more at www.simmonsfirm.com.

Media Contact
Media@simmonsfirm.com

SOURCE: Simmons Hanly Conroy



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/simmons-hanly-conroy-named-partner-jayne-conroy-honored-with-202-1195562

© 2026 ACCESS Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.